Methods and Protocols

      Analysis of aromatic amines in THS aerosol

      PMI

      Published on
      Mar 2, 2017
      Topic
      Summary

      The aerosols are generated on a linear smoking machine and collected using a Cambridge filter pad (CFP) followed by an impinger filled with 15 mL of a 5% hydrochloric acid solution. The content of the CFP is combined and extracted with the content of the impinger after addition of internal standards. The resulting solution is then cleaned and trace-enriched using a solid-phase extraction procedure (SPE) and basified. The basic extract is further cleaned and trace-enriched using a second SPE. The obtained solution is derivatized with heptafluorobutyric anhydride (HFBA).

      The derivatized solutions are analyzed by Gas Chromatography with Negative Chemical Ionization Mass Spectrometry detection (GC-NCI-MS) using a column DB-5M, 30 m x 0.25 mm ID x 0.25 µm film thickness. Results are expressed as ng/item for the Tobacco Heating System (THS), referred to as Platform 1 (P1) in the method.  

      Related Publications

      Indoor Air Chemistry - An exploratory study on e-cigarette shows no negative impact on indoor air quality

      Aerosol Chemistry

      Indoor air chemistry - An exploratory study on e-cigarette shows no negative impact on indoor air quality

      Aerosol Chemistry

      Computer-Assisted Structure Identification (CASI) for high-throughput identification of small molecules using GC×GC-HRAM-TOFMS high-resolution accurate mass spectrometry

      Aerosol Chemistry

      Computer-Assisted Structure Identification (CASI) for high-throughput identification of small molecules using GC×GC-HRAM-TOFMS high-resolution accurate mass spectrometry

      Aerosol Chemistry

      Air quality assessment during indoor use of the Tobacco Heating System 2.2

      Aerosol Chemistry

      Air quality assessment during indoor use of the Tobacco Heating System THS 2.2

      Aerosol Chemistry

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.